Best of the Week
Most Popular
1.What Happened to the Stock Market Crash Experts Were Predicting - Sol_Palha
2.London Housing Market Property Bubble Vulnerable To Crash - GoldCore
3.The Plan to Control ALL Your Money is Now at Advanced Stage
4.Why Gold Is Set For An Epic Rally This Spring - James Burgess
5.MR ROBOT NHS Cyber Attack Hack - Why Israel, NSA, CIA and GCHQ are Culpable - Nadeem_Walayat
6.Emmanuel Macron and Banking Elite Win French Presidential Election 2017 - Nadeem_Walayat
7.Trend Lines Met, Technical's are Set - US Dollar is Ready to Rally (Elliott Wave Analysis) - Enda_Glynn
8.The Student Debt Servitude Sham - Gordon_T_Long
9.Czar Trump Fires Comey, Terminates Deep State FBI, CIA Director Next? - Nadeem_Walayat
10.UK Local Elections 2017 - Labour Blood Bath, UKIP Death, Tory June 8th Landslide - Nadeem_Walayat
Last 7 days
SPX/NDX/NAZ Hit New All-time Highs - 27th May 17
GBPUSD Top in Place, GOLD Price Ready to Rocket? - 27th May 17
Silver Mining Stocks Fundamentals - 27th May 17
BBC Newsnight Falls for FAKE POLLS, Opinion Pollsters Illusion for Mainstream Media to Sell - 27th May 17
UK Local Election Results Forecast for General Election 2017 - 26th May 17
Stock Market & Crude Oil Forecast! - 26th May 17
Opinion Pollsters UK General Election Seats Forecasts 2017 - 26th May 17
Bitcoin and AltCoins Crypto Price Correction - 26th May 17
Bearish Head and Shoulders in EURUSD? - 26th May 17
SELL US Stocks - Massive Market CRASH WARNING! - 26th May 17
EURGBP: A Picture of Elliott Wave Precision - 26th May 17
Credit Downgrades May Prompt Stock Market Capital Shift - 26th May 17
Rosenstein and Mueller: the Regime Change Tag-Team - 25th May 17
Stock Market Top - Are We There Yet? - 25th May 17
Should I Invest My Fortune in Gold? Inaugural Lecture by Dr Brian Lucey - 25th May 17
USD/CAD Continues Decline - 25th May 17
Bitcoin Price Goes Loco! Surges through $2,500 Despite Unclear Fork Issues - 25th May 17
The US-Saudi Arms Deal - Sordid Saudi Signals - 25th May 17
The No.1 Commodity Play In The World Today - 24th May 17
Marks and Spencer Profits Collapse, Latest Retailer Hit by Brexit Inflation Tsunami 2017 - 24th May 17
Why Online Trading Platforms Are Useful for Everyone - 24th May 17
The Stock Market Will Tank Hard - 24th May 17
It’s Better to Buy Gold & Silver When It DOESN’T Feel Good - 24th May 17
Global Warming - Saving Us From Us - 24th May 17
Stock Market Forecast for Next 3 Months - Video - 23rd May 17
Shale Oil & Gas Production Costs Spiral Higher As Monstrous Decline Rates Eat Into Cash Flows - 23rd May 17
The Only Metal Trump Wants More Than Gold - 23rd May 17
America's Southern Heritage is a Threat to the Deep State - 23rd May 17
Manchester Bombing - ISIS Islamic Terrorist Attack Attempt to Influence BrExit Election - 23rd May 17
What an America First Trade Policy Could Mean for the US Dollar - 22nd May 17
Gold and Sillver Markets - Silver Price Sharp Selloff - 22nd May - 22nd May 17
Stock Market Volatile C-Wave - 22nd May 17
Stock Market Trend Forecast and Fear Trading - 22nd May 17
US Dollar Cycle : Deep Dive - 21st May 17
Bitcoin Breaks the $2,000 Mark as Cryptocurrencies Continue to Explode Higher - 21st May 17
Stocks, Commodities and Gold Multi-Market Status - 21st May 17
Stock Market Day Trading Strategies and Brief 20th May 2017 - 21st May 17
DOW Needs to Rally Big or Correction is Next - 20th May 17
EURUSD reaches DO or DIE moment! - 20th May 17
How to Get FREE Walkers Crisps Multi-packs! £5 to £28k Pay Packet Promo - 20th May 17

Market Oracle FREE Newsletter

Why 95% of Traders Fail

Here’s How Pharma Is Using AI Deep Learning To Cure Aging

Companies / AI Mar 16, 2017 - 10:20 AM GMT

By: John_Mauldin

Companies

BY PATRICK COX : In 2011, scientists made one of the most important discoveries in the history of AI development. They found that graphics processing units (GPUs) are far better at simulating biological learning than central processing units (CPUs).

In retrospect, it seems obvious. Human brains are much more like GPUs than CPUs. Both brains and GPUs rely on parallel processing that simulates and predicts real world physics.


In light of this, AI developers created powerful deep neural networks (DNNs) that emulate human brain function. All the major advances in self-driving cars and language translation are the result of this.

Below is a chart from Nvidia. It shows the explosive progress of AI running the Caffe deep learning platform:

In the meantime, pharma is tapping into this breakthrough to cure the diseases of aging and cut healthcare costs.

Deep Learning and Aging

One company that took on aging is InSilico Medicine. InSilico is one of the biotech companies I write about in my weekly publication, Tech Digest (subscribe here for free). The company uses DNNs to sort through huge amounts of biological data. The DNNs look for biomarkers (measurable indicators of your biological state such as those included in blood tests) that correlate with aging. For humans, this would be an impossibly complicated and time-consuming task.

InSilico has developed a program that will guess your age within a few years based on a standard blood test. Why should you care?

The reason is that biomarkers indicating old age can be altered. We can identify compounds that can make your biomarkers—and you—younger and healthier. A few of these compounds are already known. But scientists lacked the technology to identify the most powerful ones... until now.

Today, there is a race to find the most effective and safest geroprotectors. These are compounds that can restore you and your biomarkers to a more youthful profile.

One player in this field is the Life Extension Foundation (LEF). It’s on a mission to find safe and effective natural geroprotectors without regulatory delays and costs.

Last week, InSilico Medicine announced a product called Ageless Cell. It was developed in collaboration with LEF’s head of R&D Andrew Swick, PhD, former Director of Cardiovascular and Metabolic Diseases at Pfizer Global Research and Development. The supplement contains four natural compounds that DNNs have shown can rejuvenate older cells.

LEF has access to blood tests from its customers who take the product. That means data should be available in less than a year. If it works, we can expect other DNN-developed geroprotectors.

Investment Implications

Many biotech companies, including startups, are using AI. That means investors can bet on this trend without exposure to the volatility of biotech startups.

Nvidia (NVDA) is the obvious way to play the growth of DNN applications. The company may have been overvalued at one point, but several negative reports drove its price back to bargain levels.

One indication of the potential of this company comes from Insilico Medicine’s CEO. He told me that the company ran calculations for the LEF supplement on a 40 Tflop 4xNvidia Titan X (Pascal architecture) supercomputer. Since then, Insilico built another GPU cluster using 16xTitan X (Pascal), delivering 160 Tflops in GPU computing power. 

Despite a collaborative relationship with Nvidia, Insilico couldn’t get all the Nvidia GPUs it needed for the project due to high demand for the processors. This points to strong growth potential in this market.

While Nvidia pioneered dedicated GPUs for AI, chip giant Intel (INTC) is catching up. Last year, Intel bought AI startup Nervana and integrated its deep learning architecture into Xeon microprocessors. Intel also benefits from an arrangement with Google to advance AI in multicloud environments.

One tech giant that doesn’t seem to be riding this wave is IBM. Big Blue made a big mistake by underestimating the market for AI computer components. Instead, IBM invested in its own cognitive system called Watson. IBM may expand its AI product line, but we’ll have to see if the shift comes in time to compete with Nvidia and Intel.

In any case, advanced AI is not just a marginal improvement in analytical tools. It’s the only technology capable of exploiting the massive knowledge gained from human genome sequencing.

Stay in the Loop on Life-Extending Research with Patrick Cox's Tech Digest

This weekly newsletter by biotech expert Patrick Cox highlights research that is much more advanced than most people know, and the profit potential for investors is vast. Read about the latest breakthroughs—from new, non-invasive cancer treatments to age-reversing nutraceuticals and vaccines that kill any virus–as well as the innovative companies that work on them. Get Tech Digest free in your inbox every Monday.

John Mauldin Archive

© 2005-2016 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in

Catching a Falling Financial Knife